TOP TIERMARKET NEWSWIRE

News & sentiment

DISC MEDICINE INC (IRON) — News & AI sentiment

DISC MEDICINE INC (IRON) news roundup. 6 stories in the past week, 51 over 30 days. Average 30-day sentiment is 57.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 8 sales totalling $13.6M — net selling of $13.6M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

6

avg sentiment 46.7/100

30d stories

51

avg sentiment 57.4/100

Insider net (90d)

$13.6M

0 buys · 8 sells

Congress (90d)

0

0 buys · 0 sells

IRON news in the last 24 hours, 7 days, 30 days and 90 days

How much IRON coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	IRON stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	6	46.7/100	IRON headlines →
Last 30 days	51	57.4/100	IRON headlines →
Last 90 days	74	55.5/100	IRON headlines →

Latest stories on IRON

iShares Russell 2000 (IWM) Buys $8.5 Million More Disc Medicine on Friday

GuruFocus53 · neutralgeneral

1d ago

Disc Medicine, Inc. (IRON) files 8-K

SEC 8-K50 · neutralgeneral

6d ago

Disc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP - Slideshow

Seeking Alpha63 · neutralproduct/pr

7d ago

Jefferies raises Disc Medicine stock price target on drug opportunity

Investing.com Analyst Ratings64 · neutralanalyst

7d ago

Majority of Disc Medicine 6M share offering goes to 10 investors: report

Seeking Alpha28 · bearishgeneral

7d ago

Disc Medicine prices a $450 million upsized stock offering at $75 as it funds bitopertin commercialization work October 21, 2026

MarketChameleon22 · bearishgeneral

Oct 21

Why is Disc Medicine stock sliding today?

Investing.com Markets38 · neutralgeneral

Oct 21

Disc Medicine price target raised to $110 from $100 at Wedbush

The Fly64 · neutralanalyst

Oct 21

Disc Medicine sets $75 share price for $450M offering

Seeking Alpha22 · bearishgeneral

Oct 21

Disc Medicine 6M share Secondary priced at $75.00

The Fly28 · bearishgeneral

Oct 21

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock

GlobeNewswire22 · bearishgeneral

Oct 21

Disc Medicine Announces Pricing of $450 Million Upsized Public Offering of Common Stock

StockTitan22 · bearishgeneral

Oct 21

Disc Medicine stock price target raised to $115 by Truist on drug outlook

Investing.com Analyst Ratings64 · neutralanalyst

Oct 20

Disc Medicine price target raised to $115 from $83 at Truist

The Fly64 · neutralanalyst

Oct 20

Disc Medicine price target raised to $170 from $125 at Cantor Fitzgerald

The Fly64 · neutralanalyst

Oct 20

Disc Medicine price target raised to $92 from $90 at Morgan Stanley

The Fly63 · neutralanalyst

Oct 20

Cantor Fitzgerald raises Disc Medicine stock price target on trial data

Investing.com Analyst Ratings64 · neutralanalyst

Oct 20

Disc Medicine: APOLLO Changes The Story, But How Much Upside Remains

Seeking Alpha74 · bullishproduct/pr

Oct 20

Disc Medicine price target raised to $124 from $86 at Wells Fargo

The Fly64 · neutralanalyst

Oct 20

Wells Fargo raises Disc Medicine stock price target on competitive profile

Investing.com Analyst Ratings63 · neutralanalyst

Oct 20

Disc Medicine announces $350M common stock, warrants offering

The Fly22 · bearishgeneral

Oct 19

Disc Medicine launches $350M public offering of common stock and pre-funded warrants

Seeking Alpha22 · bearishgeneral

Oct 19

Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire22 · bearishgeneral

Oct 19

Disc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP Transcript

Seeking Alpha58 · neutralproduct/pr

Oct 19

Disc Medicine price target raised to $115 from $83 at Truist

The Fly64 · neutralanalyst

Oct 19

Open IRON in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →